# Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients

> **NCT02238457** · PHASE4 · WITHDRAWN · sponsor: **Baker Heart and Diabetes Institute**

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Low dose losartan
- **DRUG:** High dose losartan

## Key facts

- **NCT ID:** NCT02238457
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty recruiting patients
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02238457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02238457, "Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02238457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*